AstraZeneca PLC (AZN.ST) Financials
AZN.ST Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 1.0 trillion | 624.0 billion |
| 2023-09-30 | 1.0 trillion | 642.8 billion |
| 2023-06-30 | 1.0 trillion | 641.7 billion |
| 2023-03-31 | 1.0 trillion | 630.9 billion |
AZN.ST Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 14.4 billion | ? |
| 2023-09-30 | 24.4 billion | ? |
| 2023-06-30 | 13.4 billion | ? |
| 2023-03-31 | 17.2 billion | ? |
AZN.ST Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 9.0 billion |
| 2023-09-30 | 18.0 billion |
| 2023-06-30 | 22.7 billion |
| 2023-03-31 | 23.4 billion |
AZN.ST Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 59.0 billion | - | 11.4 billion |
| 2023-09-30 | 55.9 billion | - | 10.7 billion |
| 2023-06-30 | 63.1 billion | - | 10.3 billion |
| 2023-03-31 | 67.0 billion | - | 10.0 billion |
AZN.ST Shares Outstanding
AZN.ST Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 9.5 billion | 31.0 billion | -139.5 billion | 179.6 billion |
| 2023-09-30 | 9.6 billion | 28.2 billion | 52.4 billion | 53.8 billion |
| 2023-06-30 | 5.2 billion | 28.9 billion | 54.1 billion | 55.5 billion |
| 2023-03-31 | 15.2 billion | 27.1 billion | 42.1 billion | 43.5 billion |
AZN.ST Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 121.1 billion | 23.2 billion |
| 2023-09-30 | 125.5 billion | 22.9 billion |
| 2023-06-30 | 123.9 billion | 21.3 billion |
| 2023-03-31 | 112.7 billion | 19.7 billion |
AZN.ST
Price: SEK1,634
Dividend Yield: 0.00%
Forward Dividend Yield: 2.53%
Payout Ratio: 102.20%
Dividend Per Share: 41.30 SEK
Earnings Per Share: 40.41 SEK
P/E Ratio: 34.93
Exchange: STO
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 2.2 trillion
Average Dividend Frequency: 2
Years Paying Dividends: 25
DGR3: 4.77%
DGR5: 6.68%
DGR10: 5.57%
DGR20: 9.04%